Bristol-Myers Squibb Aktie

Kaufen
Verkaufen
54,65 EUR -0,88 EUR -1,58 %
56,30 USD +0,01 USD +0,02 %
nachbörslich
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 111,2 Mrd. EUR

KGV 13,29 Div. Rendite 4,50%

WKN 850501

ISIN US1101221083

Symbol BMY


Bristol-Myers Squibb Aktie Analyse

03.05.19 Bristol-Myers Squibb overweight Barclays Capital
07.12.18 Bristol-Myers Squibb Outperform BMO Capital Markets
27.04.18 Bristol-Myers Squibb Market Perform BMO Capital Markets
15.02.18 Bristol-Myers Squibb overweight Morgan Stanley
05.05.17 Bristol-Myers Squibb Underperform BMO Capital Markets
28.10.16 Bristol-Myers Squibb Hold Deutsche Bank AG
09.09.16 Bristol-Myers Squibb Equal weight Barclays Capital
23.05.16 Bristol-Myers Squibb Neutral J.J.B. Hilliard, W.L. Lyons, Inc.
29.04.16 Bristol-Myers Squibb Equal weight Barclays Capital
29.04.16 Bristol-Myers Squibb Buy UBS AG
01.12.15 Bristol-Myers Squibb Equal weight Barclays Capital
27.02.15 Bristol-Myers Squibb Buy Argus Research Company
12.01.15 Bristol-Myers Squibb Buy Argus Research Company
27.10.14 Bristol-Myers Squibb Sell MKM Partners
17.10.14 Bristol-Myers Squibb Outperform BMO Capital Markets
02.07.14 Bristol-Myers Squibb Equal weight Barclays Capital
12.07.13 Bristol-Myers Squibb halten Jefferies & Company Inc.
10.12.12 Bristol-Myers Squibb neutral UBS AG
03.12.12 Bristol-Myers Squibb neutral Citigroup Corp.
12.09.12 Bristol-Myers Squibb buy Goldman Sachs Group Inc.
02.08.12 Bristol-Myers Squibb neutral UBS AG
26.07.12 Bristol-Myers Squibb neutral UBS AG
20.07.12 Bristol-Myers Squibb neutral UBS AG
22.06.12 Bristol-Myers Squibb neutral Credit Suisse Group
30.04.12 Bristol-Myers Squibb overweight Barclays Capital
30.01.12 Bristol-Myers Squibb overweight Barclays Capital
10.01.12 Bristol-Myers Squibb overweight Barclays Capital
08.11.11 Bristol-Myers Squibb buy Citigroup Corp.
31.10.11 Bristol-Myers Squibb overweight Barclays Capital
27.10.11 Bristol-Myers Squibb neutral UBS AG
26.10.11 Bristol-Myers Squibb buy Citigroup Corp.
06.10.11 Bristol-Myers Squibb buy Banc of America Securities-Merrill Lynch
03.08.11 Bristol-Myers Squibb buy Citigroup Corp.
01.08.11 Bristol-Myers Squibb buy Citigroup Corp.
21.07.11 Bristol-Myers Squibb overweight Barclays Capital
20.07.11 Bristol-Myers Squibb buy Citigroup Corp.
12.07.11 Bristol-Myers Squibb buy Citigroup Corp.
27.06.11 Bristol-Myers Squibb neutral UBS AG
27.06.11 Bristol-Myers Squibb neutral UBS AG
24.06.11 Bristol-Myers Squibb buy Citigroup Corp.
24.06.11 Bristol-Myers Squibb buy Citigroup Corp.
24.06.11 Bristol-Myers Squibb overweight Barclays Capital
24.06.11 Bristol-Myers Squibb neutral Credit Suisse Group
24.06.11 Bristol-Myers Squibb overweight Morgan Stanley
23.06.11 Bristol-Myers Squibb neutral UBS AG
15.06.11 Bristol-Myers Squibb neutral UBS AG
01.06.11 Bristol-Myers Squibb buy Citigroup Corp.
12.05.11 Bristol-Myers Squibb neutral Goldman Sachs Group Inc.
02.05.11 Bristol-Myers Squibb overweight Barclays Capital
19.04.11 Bristol-Myers Squibb overweight Barclays Capital